Assenagon Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $285M | Buy |
|
|||||
|
2025
Q2 | $287M | Buy |
|
|||||
|
2025
Q1 | $251M | Buy |
|
|||||
|
2024
Q4 | $84.8M | Sell |
|
|||||
|
2024
Q3 | $327M | Buy |
|
|||||
|
2024
Q2 | $227M | Sell |
|
|||||
|
2024
Q1 | $212M | Buy |
|
|||||
|
2023
Q4 | $119M | Sell |
|
|||||
|
2023
Q3 | $172M | Buy |
|
|||||
|
2023
Q2 | $168M | Buy |
|
|||||
|
2023
Q1 | $96.7M | Sell |
|
|||||
|
2022
Q4 | $114M | Sell |
|
|||||
|
2022
Q3 | $146M | Buy |
|
|||||
|
2022
Q2 | $116M | Buy |
|
|||||
|
2022
Q1 | $136M | Buy |
|
|||||
|
2021
Q4 | $85.8M | Sell |
|
|||||
|
2021
Q3 | $184M | Buy |
|
|||||
|
2021
Q2 | $149M | Buy |
|
|||||
|
2021
Q1 | $131M | Sell |
|
|||||
|
2020
Q4 | $190M | Buy |
|
|||||
|
2020
Q3 | $31.9M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $19M | Sell |
|
|||||
|
2019
Q4 | $65.9M | Buy |
|
|||||
|
2019
Q3 | $3.14M | Sell |
|
|||||
|
2019
Q2 | $14.6M | Sell |
|
|||||
|
2019
Q1 | $26.6M | Buy |
|
|||||
|
2018
Q4 | $2.64M | Buy |
|
|||||
|
2018
Q3 | $428K | Sell |
|
|||||
|
2018
Q2 | $8.5M | Sell |
|
|||||
|
2018
Q1 | $7.45M | Sell |
|
|||||
|
2017
Q4 | $10.8M | Buy |
|
|||||
|
2017
Q3 | $4.88M | Buy |
|
|||||
|
2017
Q2 | $4.07M | Buy |
|
|||||
|
2017
Q1 | $815K | Sell |
|
|||||
|
2016
Q4 | $34.7M | Buy |
|